GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DRI Healthcare Trust (OTCPK:DHTRF) » Definitions » Float Percentage Of Total Shares Outstanding

DHTRF (DRI Healthcare Trust) Float Percentage Of Total Shares Outstanding : 0.00% (As of May. 09, 2025)


View and export this data going back to 2023. Start your Free Trial

What is DRI Healthcare Trust Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, DRI Healthcare Trust's float shares is 0.00 Mil. DRI Healthcare Trust's total shares outstanding is 56.31 Mil. DRI Healthcare Trust's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, DRI Healthcare Trust's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, DRI Healthcare Trust's Institutional Ownership is 23.98%.


DRI Healthcare Trust Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

DRI Healthcare Trust's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/56.31
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DRI Healthcare Trust Business Description

Industry
Traded in Other Exchanges
Address
100 King Street West, 1 First Canadian Place, Suite 7250, Toronto, ON, CAN, M5X 1B1
DRI Healthcare Trust is engaged in pharmaceutical royalty monetization by providing capital to inventors, academic institutions, and biopharma companies. Trust was formed to provide Unitholders with differential exposure to the pharmaceutical and biotechnology industries through ownership and acquisitions of pharmaceutical royalties. In return for providing capital to biopharmaceutical innovators, the company is building a diversified portfolio of interests in medicines that have a demonstrable positive impact on the world. The Trust has concluded that it operates as one segment, focused on acquiring royalty assets. Geographically the trust generates it's key revenue from the United States. The trust also generates Income from markets such as Japan, and the European Union.